IRILIEVA 100 MG (Irinotecan Hydrochloride Injection 100 mg) is a prescription anticancer medicine used in the treatment of various solid tumors, particularly colorectal cancer. It contains Irinotecan Hydrochloride 100 mg, a chemotherapy agent that belongs to the class of medicines known as topoisomerase I inhibitors. The medicine works by interfering with the DNA replication process of cancer cells, helping to slow or stop their growth and spread.

Cancer cells divide rapidly and continuously. Irinotecan targets these rapidly multiplying cells by blocking the activity of an enzyme called topoisomerase I, which is essential for DNA replication and cell division. As a result, cancer cells are unable to reproduce effectively and eventually die, helping to control tumor growth and disease progression.

IRILIEVA 100 MG is widely used in modern oncology treatment protocols and may be administered alone or in combination with other chemotherapy medicines. It plays a significant role in the treatment of advanced and metastatic cancers, particularly gastrointestinal malignancies.

This medicine is commonly prescribed for:

     • Metastatic Colorectal Cancer

     • Advanced Colon Cancer

     • Rectal Cancer

     • Gastrointestinal Cancers

     • Combination Chemotherapy Protocols

     • Advanced Solid Tumors

     • Oncology Treatment Programs

     • Long-Term Cancer Management

Irinotecan is often included in internationally recognized chemotherapy regimens and may be combined with other anticancer medicines to improve treatment effectiveness and patient outcomes.

Manufactured under stringent pharmaceutical quality standards, IRILIEVA 100 MG is designed to provide reliable therapeutic performance, safety, and consistency. The medicine should only be administered by qualified healthcare professionals in hospitals, oncology centers, or specialized treatment facilities.

Patients receiving Irinotecan therapy typically require regular blood tests, liver function monitoring, kidney assessments, and medical evaluations to ensure safe and effective treatment. These assessments help monitor treatment response and identify potential side effects at an early stage.

Due to its proven effectiveness in cancer treatment, IRILIEVA 100 MG remains an important component of modern chemotherapy and oncology care programs worldwide.

IRILIEVA 100 MG (Irinotecan Hydrochloride Injection 100 mg) is primarily used for the treatment and management of several types of cancer.

Common Uses of IRILIEVA 100 MG

1. Metastatic Colorectal Cancer

The medicine is widely used in patients with colorectal cancer that has spread to other parts of the body.

2. Colon Cancer

Doctors may prescribe Irinotecan as part of combination chemotherapy regimens for advanced colon cancer.

3. Rectal Cancer

IRILIEVA may be included in treatment plans for rectal cancer depending on the stage and treatment goals.

4. Gastrointestinal Malignancies

The medicine is used in selected gastrointestinal cancers under specialist oncology supervision.

5. Combination Chemotherapy Programs

Irinotecan is frequently combined with other anticancer medicines to improve treatment outcomes.

6. Advanced Solid Tumors

The medicine may be prescribed for certain advanced cancers as recommended by oncologists.

---

How IRILIEVA 100 MG Works

Irinotecan belongs to a class of medicines called Topoisomerase I Inhibitors.

IRILIEVA works by:

     • Blocking the topoisomerase I enzyme

     • Interfering with DNA replication

     • Preventing cancer cell division

     • Slowing tumor growth

     • Helping destroy rapidly multiplying cancer cells

     • Supporting effective chemotherapy treatment

This mechanism helps control cancer progression and supports modern oncology care.

Like all chemotherapy medicines, IRILIEVA 100 MG may cause side effects in some patients. Side effects vary depending on individual response, treatment duration, and overall health condition.

Common Side Effects

1. Diarrhea

Diarrhea is one of the most frequently reported side effects and may occur early or late during treatment.

2. Nausea

Patients may experience nausea during chemotherapy sessions.

3. Vomiting

Episodes of vomiting may occur in some individuals.

4. Fatigue

Weakness, tiredness, and low energy levels are commonly reported.

5. Loss of Appetite

Reduced appetite may occur during treatment.

6. Hair Loss

Temporary hair thinning or hair loss may develop.

7. Abdominal Pain

Some patients may experience stomach cramps or abdominal discomfort.

8. Fever

Mild fever may occasionally occur during therapy.

9. Low Blood Cell Counts

Irinotecan may reduce:

     • White blood cell counts

     • Red blood cell counts

     • Platelet counts

---

Serious Side Effects

Seek immediate medical attention if you experience:

     • Severe diarrhea

     • High fever

     • Difficulty breathing

     • Severe allergic reactions

     • Unusual bleeding or bruising

     • Persistent vomiting

     • Severe dehydration

     • Signs of serious infection

     • Severe abdominal pain

Patients should immediately contact their healthcare provider if serious symptoms develop.

The dosage of IRILIEVA 100 MG (Irinotecan Hydrochloride Injection 100 mg) should always be determined by a qualified oncologist or healthcare professional.

Factors Affecting Dosage

1. Type of Cancer

Dosage depends on the cancer diagnosis and treatment protocol.

2. Body Surface Area (BSA)

Chemotherapy dosing is commonly calculated according to body size.

3. Liver Function

Patients with liver impairment may require dosage modifications.

4. Treatment Response

Doctors may adjust treatment based on effectiveness and tolerability.

5. Combination Therapy

Dosage may vary when used with other chemotherapy medicines.

---

Important Dosage Instructions

     • The injection should only be administered by trained healthcare professionals.

     • Follow the prescribed chemotherapy schedule carefully.

     • Attend all treatment sessions and monitoring appointments.

     • Regular blood tests are essential during therapy.

     • Do not miss scheduled oncology consultations.

     • Treatment modifications should only be made by your healthcare provider.

---

Precautions Before Using IRILIEVA 100 MG

Before receiving treatment, patients should inform their doctor if they have:

     • Liver disease

     • Kidney disease

     • Blood disorders

     • Active infections

     • Previous chemotherapy-related complications

     • Allergies to medications

Patients should also disclose all prescription medicines, supplements, and herbal products they are currently using to avoid possible drug interactions.

Pregnant or breastfeeding women should only receive this medicine if specifically recommended by a healthcare professional.

---

Storage Instructions

     • Store according to the instructions provided on the product label.

     • Protect from direct sunlight and excessive heat.

     • Keep out of reach of children.

     • Follow hospital and pharmacy storage recommendations.

---

Why Choose IRILIEVA 100 MG?

     • Trusted Irinotecan Hydrochloride formulation

     • Effective chemotherapy treatment option

     • Supports colorectal cancer management

     • Used in internationally recognized oncology protocols

     • Manufactured under strict pharmaceutical quality standards

     • Reliable therapeutic performance

     • Suitable for advanced cancer treatment programs

---

Frequently Asked Questions (FAQs)

What is IRILIEVA 100 MG used for?

It is primarily used for the treatment of colorectal cancer and certain other advanced solid tumors.

What is Irinotecan Hydrochloride?

Irinotecan Hydrochloride is a chemotherapy medicine that blocks cancer cell DNA replication and helps slow tumor growth.

Is IRILIEVA a chemotherapy medicine?

Yes, it is a chemotherapy medicine belonging to the topoisomerase I inhibitor class.

Can IRILIEVA be used with other cancer medicines?

Yes, it is often used as part of combination chemotherapy regimens.

What is the most common side effect of Irinotecan?

Diarrhea is one of the most commonly reported side effects and should be monitored carefully.

Is regular monitoring necessary during treatment?

Yes, doctors typically recommend blood tests, liver function monitoring, and routine medical evaluations throughout therapy.

Can patients stop treatment without consulting their doctor?

No, chemotherapy treatment should only be modified or discontinued under medical supervision.

Should IRILIEVA be administered under medical supervision?

Yes, this medicine should only be administered by qualified healthcare professionals experienced in oncology and chemotherapy treatment.